The family of inflammatory/autoimmune systemic diseases (IAD) form a continuum from pure inflammatory diseases to pure autoimmune diseases, encompassing a large panel of inflammatory diseases with some autoimmune components, and vice versa. Cross phenotyping of patients with IAD should be heuristic and help revise the nosography and the understanding of these diseases.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Total peripheral blood gene expression between patients, expressed as fluorescence intensity
Timeframe: at day 0, no follow-up
Tregs and Tconvs T cell receptor repertoire, expressed as the % of unique TCR sequences
Timeframe: at day 0, no follow-up
HLA type and SNPs expressed as the occurrence events across patients
Timeframe: at day 0, no follow-up
Microbiote species identification expressed as the % of species per family and genus
Timeframe: at day 0, no follow-up
Cytokines and chemokines expressed as fluorescence intensity
Timeframe: at day 0, no follow-up
Immune cells phenotyping expressed as the each cell type % within total PBMCs
Timeframe: at day 0, no follow-up